In a report released today, Bill Kirk from Roth MKM reiterated a Hold rating on Aurora Cannabis (ACB – Research Report), with a price target of ...
Roth MKM analyst Jason Wittes maintained a Buy rating on Journey Medical Corp (DERM – Research Report) today and set a price target of $11.00.
Roth MKM lowered the firm’s price target on Snap (SNAP) to $12 from $14 and keeps a Neutral rating on the shares. The company ...
Roth MKM analyst Philip Shen lowered the firm’s price target on Enphase Energy (ENPH) to $90 from $100 and keeps a Buy rating ...
The Lockheed L-1011 'TriStar' was one of the defining aircraft of the early widebody era and the third twin-aisle jet to ...
Roth Mkm restated their buy rating on shares of TriSalus Life Sciences (NASDAQ:TLSI – Free Report) in a research report ...
Roth MKM keeps a Buy rating and $38 price target on Digi International (DGII) following its non-deal roadshow with the management team. The firm comes away from the discussions “cautiously ...
Fintel reports that on February 4, 2025, Roth MKM upgraded their outlook for AMC Entertainment Holdings (NYSE:AMC) from Sell ...
Roblox (NYSE:RBLX – Free Report) had its target price lifted by Roth Mkm from $54.00 to $70.00 in a research report report ...